Differential outcomes and immune checkpoint inhibitor response among endometrial cancer patients with MLH1 hypermethylation versus MLH1 “Lynch-like” mismatch repair gene mutation

MLH1 子宫内膜癌 癌症研究 医学 DNA错配修复 微卫星不稳定性 肿瘤科 林奇综合征 癌症 内科学 生物 结直肠癌 遗传学 基因 微卫星 等位基因
作者
Michael Driscoll Toboni,Sharon K. Wu,Alex Patrick Farrell,Joanne Xiu,Jennifer R. Ribeiro,Matthew James Oberley,Rebecca Christian Arend,Britt Kristina Erickson,Thomas J. Herzog,Premal H. Thaker,Matthew A. Powell
出处
期刊:Gynecologic Oncology [Elsevier BV]
卷期号:177: 132-141 被引量:33
标识
DOI:10.1016/j.ygyno.2023.08.015
摘要

Abstract

Objectives

To identify differential survival outcomes and immune checkpoint inhibitor (ICI) response in MLH1 hypermethylated versus MLH1 mutated ("Lynch-like") endometrial tumors and determine whether their molecular profiles can elucidate the differential outcomes.

Methods

1673 mismatch repair deficient endometrial tumors were analyzed by next-generation sequencing and whole transcriptome sequencing (Caris Life Sciences, Phoenix, AZ). PD-L1, ER, and PR were tested by immunohistochemistry and immune cell infiltrates were calculated using MCP-counter. Significance was determined using Chi-square and Mann-Whitney U tests and adjusted for multiple comparisons. Overall survival (OS) was depicted using Kaplan-Meier survival curves.

Results

The endometrial cancer cohort comprised 89.2% patients with MLH1 hypermethylated tumors and 10.8% with MLH1 mutated tumors, with median ages of 67 and 60 years, respectively (p < 0.01). Patients with MLH1 hypermethylated tumors had significantly worse OS and trended toward worse OS following ICI treatment than patients with MLH1 mutated tumors. The immune microenvironment of MLH1 hypermethylated relative to MLH1 mutated was characterized by decreased PD-L1 positivity, immune checkpoint gene expression, immune cell infiltration, T cell inflamed scores, and interferon gamma (IFNγ) scores. MLH1 hypermethylation was also associated with decreased mutation rates in TP53 and DNA damage repair genes, but increased rates of JAK1, FGFR2, CCND1, and PTEN mutations, as well as increased ER and PR positivity.

Conclusions

Endometrial cancer patients with MLH1 hypermethylation display significantly decreased survival and discrepant immunotherapy responses compared to patients with MLH1 mutated tumors, which was associated with differential mutational profiles, a more immune cold phenotype, and increased ER/PR expression in MLH1 hypermethylated tumors. Providers may consider early transition from single agent ICI to a multi-agent regimen or hormonal therapy for patients with MLH1 hypermethylated tumors.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
袁志阳发布了新的文献求助10
1秒前
1秒前
JinLy完成签到,获得积分10
2秒前
威武雨柏完成签到,获得积分10
2秒前
传奇3的应助被稳重的大侠采纳,获得10
2秒前
和谐天川完成签到 ,获得积分10
3秒前
YAAH发布了新的文献求助10
3秒前
shidewu发布了新的文献求助10
3秒前
moonlight发布了新的文献求助10
4秒前
4秒前
4秒前
4秒前
5秒前
5秒前
wz1666发布了新的文献求助10
5秒前
圆圆完成签到,获得积分10
6秒前
脑洞疼的应助被xy采纳,获得15
6秒前
攀登完成签到,获得积分10
7秒前
Jun的应助被苏鸣雅采纳,获得10
7秒前
氮气完成签到,获得积分10
7秒前
8秒前
8秒前
所所的应助被酷酷柚子采纳,获得10
8秒前
打开电脑完成签到,获得积分20
8秒前
yy完成签到,获得积分10
9秒前
9秒前
周博士发布了新的文献求助10
9秒前
了了发布了新的文献求助10
10秒前
Cristol发布了新的文献求助10
10秒前
土豆完成签到,获得积分10
10秒前
Dingkf118完成签到 ,获得积分10
10秒前
11秒前
11秒前
11秒前
鱼鱼完成签到,获得积分10
12秒前
马嘎嘎发布了新的文献求助10
12秒前
HAIY发布了新的文献求助30
13秒前
13秒前
13秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
plantTFDB 508
高分子基功能界面水蒸发材料与应用研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8178203
求助须知:如何正确求助?哪些是违规求助? 9568998
关于积分的说明 21802098
捐赠科研通 7773088
什么是DOI,文献DOI怎么找? 3432711
关于科研通互助平台的介绍 2556748
邀请新用户注册赠送积分活动 2478259